EZH2 and prostate carcinoma: Among them, miR-124 has been previously shown to target and downregulate Ezh2 mRNA expression during early mouse neurogenesis [28] and let-7, which has been previously associated with Ezh2 mRNA control in prostate cancer cells [39].